Search results for "MRI"

showing 10 items of 733 documents

Resectable and borderline resectable pancreatic ductal adenocarcinoma: Role of the radiologist and oncologist in the era of precision medicine

2021

The incidence and mortality of pancreatic ductal adenocarcinoma are growing over time. The management of patients with pancreatic ductal adenocarcinoma involves a multidisciplinary team, ideally involving experts from surgery, diagnostic imaging, interventional endoscopy, medical oncology, radiation oncology, pathology, geriatric medicine, and palliative care. An adequate staging of pancreatic ductal adenocarcinoma and re-assessment of the tumor after neoadjuvant therapy allows the multidisciplinary team to choose the most appropriate treatment for the patient. This review article discusses advancement in the molecular basis of pancreatic ductal adenocarcinoma, diagnostic tools available fo…

Oncologymedicine.medical_specialtyMedicine (General)Palliative carePancreatic ductal adenocarcinomamagnetic resonance imaging (MRI)business.industrymedicine.medical_treatmentClinical Biochemistrypancreatic ductal adenocarcinomapancreatic neoplasmReviewcomputed tomography (CT)Precision medicineDiagnostic toolsmedicine.diseaseReview articleR5-920Borderline resectableInternal medicinePancreatic cancerMedicineRadiologybusinessNeoadjuvant therapy
researchProduct

Rectal cancer: Assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI

2012

Purpose To assess pretreatment functional and morphological tumor characteristics with magnetic resonance imaging (MRI) in advanced rectal carcinoma and to identify factors predicting response to neoadjuvant chemoradiation. Materials and Methods In a prospective study, 95 patients with rectal carcinoma underwent dynamic contrast-enhanced MRI before and after chemoradiation. Quantitative parameters were derived from a pharmacokinetic two-compartment model. Tumors were also characterized with regard to mucinous status at pretreatment high-resolution MRI as nonmucinous or mucinous. Response to treatment was defined as a downshift in the local tumor stage. Results The parameter k21 (contrast me…

Oncologymedicine.medical_specialtymedicine.diagnostic_testColorectal cancerbusiness.industryMagnetic resonance imagingOdds ratiomedicine.diseaseContrast mediumInternal medicineDynamic contrast-enhanced MRImedicineMucinous carcinomaRadiology Nuclear Medicine and imagingMucinous TumorNuclear medicinebusinessProspective cohort studyJournal of Magnetic Resonance Imaging
researchProduct

Data-driven analysis for fMRI during naturalistic music listening

2017

Interest towards higher ecological validity in functional magnetic resonance imaging (fMRI) experiments has been steadily growing since the turn of millennium. The trend is reflected in increasing amount of naturalistic experiments, where participants are exposed to the real-world complex stimulus and/or cognitive tasks such as watching movie, playing video games, or listening to music. Multifaceted stimuli forming parallel streams of input information, combined with reduced control over experimental variables introduces number of methodological challenges associated with isolating brain responses to individual events. This exploratory work demonstrated some of those methodological challeng…

PCAfMRIdimension pienennysmusiikkisignaalianalyysikognitiiviset prosessitkuunteleminenpääkomponenttianalyysinaturalistic experimenttoiminnallinen magneettikuvausICACCAaivotkernel PCA dimension reduction
researchProduct

Frequency-specific network activity predicts bradykinesia severity in Parkinson’s disease

2021

Highlights • Parallel subnetworks are affected in bradykinesia. • The primary motor and the premotor cortex are common nodes with task-specificity. • Beta activity decreases, gamma activity increases with improvement of bradykinesia. • Subthalamic stimulation reduces beta, increases gamma power in ipsilateral cortex. • Subnetworks act with frequency-specific oscillations.

PPC posterior parietal cortexBradykinesiaParkinson's diseaseDeep brain stimulationCognitive Neurosciencemedicine.medical_treatmentComputer applications to medicine. Medical informaticsR858-859.7FT finger tappingHypokinesiaElectromyographyElectroencephalographyPS pronation-supinationGamma oscillationPremotor cortexCER cerebellumSubthalamic NucleusDeep brain stimulationmedicineHumansRadiology Nuclear Medicine and imagingRC346-429SMA supplementary motor cortexM1 primary motor cortexResting state fMRImedicine.diagnostic_testbusiness.industryRegular ArticleBeta oscillationmedicine.diseasehumanitiesnervous system diseasesParkinson diseaseHG hand graspingSubthalamic nucleusCross-Sectional Studiesmedicine.anatomical_structurePMC premotor cortexNeurologyDLPFC dorsolateral prefrontal cortexFinger tappingStrEM structural equation modellingNeurology. Diseases of the nervous systemNeurology (clinical)businessNeuroscienceSTN subthalamic nucleusNeuroImage: Clinical
researchProduct

Peritumoral perfusion and proton spectroscopic MR imaging in the differentiation of gliomas and solitary metastases

2015

Purpose: To asses the value of peritumoural perfusion-weighted and proton spectroscopic MR imaging in preoperative grading of gliomas and in differentiating between primary gliomas and solitary metastases. Methods and Materials: Ten low-grade gliomas, eight high-grade gliomas, and ten metastases were prospectively evaluated with MR imaging, dynamic susceptibility contrast-enhanced perfusion imaging, and single-voxel proton MR spectroscopy before surgical resection or stereotactic biopsy. Maximal rCBV values and maximal Cho/Cr ratios were calculated from peritumoural region surrounding the tumour. Tumour grade presumed with these values was compared to histopathologic grading. Differences in…

PWI MRI MRS Glioma Metastases BrainPerfusion MR Imaging Glioma MR SpectroscopySettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Imaging of Substantia Nigra in Parkinson's Disease: A Narrative Review.

2021

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, characterized by motor and non-motor symptoms due to the degeneration of the pars compacta of the substantia nigra (SNc) with dopaminergic denervation of the striatum. Although the diagnosis of PD is principally based on a clinical assessment, great efforts have been expended over the past two decades to evaluate reliable biomarkers for PD. Among these biomarkers, magnetic resonance imaging (MRI)-based biomarkers may play a key role. Conventional MRI sequences are considered by many in the field to have low sensitivity, while advanced pulse sequences and ultra-high-field MRI techniques have brought many advantages, partic…

Parkinson's diseaseSettore MED/50 - Scienze Tecniche Mediche ApplicateSubstantia nigraNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseStriatumReview030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineironneurodegenerative diseasemedicinemagnetic resonance imagingneurodegenerative diseasesmedicine.diagnostic_testPars compactabusiness.industryGeneral NeuroscienceradiomicSettore MED/37 - NeuroradiologiabiomarkersMagnetic resonance imagingmedicine.diseaseparkinsonian disordersnigrosome-1radiomicsParkinson’s diseasebiomarkerSettore MED/26 - NeurologiaDifferential diagnosisneuromelaninbusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaNeuroscience030217 neurology & neurosurgeryDiffusion MRIRC321-571Brain sciences
researchProduct

Longitudinal 18F-FDG PET and MRI Reveal Evolving Imaging Pathology That Corresponds to Disease Progression in a Patient With ALS-FTD

2019

Single time point positron emission tomography (PET) studies of patients with amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD), have demonstrated hypometabolism or hypermetabolism in certain brain regions. To determine whether longitudinal (at baseline and 20.4 months later) PET and magnetic resonance imaging (MRI) reveal evolving brain imaging pathology corresponding to clinical progression in a patient with ALS-FTD, cerebral glucose metabolic rate, cortical thickness (CT) and cortical area (CA) were obtained and symmetric percent change (SPC) for each calculated. The patient had worsening symptoms and signs of bulbar-onset upper motor neuron-predominant ALS as well as l…

Pathologymedicine.medical_specialtyCase ReportLateralization of brain functionlcsh:RC346-429030218 nuclear medicine & medical imagingPrimary progressive aphasia03 medical and health sciences0302 clinical medicineNeuroimagingAphasiaALS-FTDMedicineAmyotrophic lateral sclerosislcsh:Neurology. Diseases of the nervous systemcortical areamedicine.diagnostic_testbusiness.industryMagnetic resonance imagingcortical thicknessmedicine.diseaseaphasiaPETNeurologyNeurology (clinical)medicine.symptombusinessNeurocognitive030217 neurology & neurosurgeryFrontotemporal dementiaMRIFrontiers in Neurology
researchProduct

Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals

2019

Fronto-limbic white matter (WM) abnormalities are assumed to lie at the heart of the pathophysiology of bipolar disorder (BD);\ud however, diffusion tensor imaging (DTI) studies have reported heterogeneous results and it is not clear how the clinical\ud heterogeneity is related to the observed differences. This study aimed to identify WM abnormalities that differentiate patients with\ud BD from healthy controls (HC) in the largest DTI dataset of patients with BD to date, collected via the ENIGMA network. We gathered\ud individual tensor-derived regional metrics from 26 cohorts leading to a sample size of N = 3033 (1482 BD and 1551 HC). Mean\ud fractional anisotropy (FA) from 43 regions of i…

Pathologymedicine.medical_specialtyCorpus callosumArticleWhite matter03 medical and health sciences0302 clinical medicineFractional anisotropyCingulum (brain)MedicineManic-depressive illnessBipolar disorderPharmacologyTrastorn bipolarbusiness.industryDiagnostic markersAnisotropiaTranslational researchmedicine.disease030227 psychiatryPsychiatry and Mental healthmedicine.anatomical_structureMeta-analysisAnisotropybusiness030217 neurology & neurosurgeryDiffusion MRITractography
researchProduct

Radiolabeled DNase, a potential indicator for noninvasive detection of tissue damage

1983

Pancreatic DNase I was labeled with 131I or fluorescamine and injected IV into NMRI mice bearing a sarcoma 180. Of the injected tracer, 1.5%-2% was found to accumulate per g tumor. In sections of tumor tissue DNase was localized in damaged cells in solid and necrotic tumor regions. This binding is most probably due to specific interaction of DNase with actin, an ubiquitous cytoskeletal protein. Two-component blood clearance with a rapid first component (two-thirds of applied radioactivity) was observed. The labeled tumor could easily be visualized by gamma camera imaging. The findings suggest DNase to be a potent radiopharmaceutical for imaging damaged tissue, occurring in malignant tumors …

Pathologymedicine.medical_specialtyDeoxyribonucleasesPancreatic DNaseGeneral MedicineFluorescaminemedicine.diseaseFluorescamineIodine RadioisotopesMicechemistry.chemical_compoundchemistryNmri miceTissue damagemedicineAnimalsFemaleTissue DistributionRadiology Nuclear Medicine and imagingNecrotic tumorSarcomaRadionuclide ImagingSarcoma 180CytoskeletonActinEuropean Journal of Nuclear Medicine
researchProduct

Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains

2020

Recent evidence of gadolinium deposition in the brain has raised safety concerns. Iron oxide nanoparticles are re-emerging as promising alternative MR contrast agents, because the iron core can be metabolized. However, long-term follow up studies of the brain after intravenous iron oxide administration have not been reported thus far. In this study, we investigated, if intravenously administered ferumoxytol nanoparticles are deposited in porcine brains. Methods: In an animal care and use committee-approved prospective case-control study, ten Gottingen minipigs received either intravenous ferumoxytol injections at a dose of 5 mg Fe/kg (n=4) or remained untreated (n=6). Nine to twelve months …

Pathologymedicine.medical_specialtyLentiform nucleusSwineGadoliniumBiomedical EngineeringCaudate nucleusMedicine (miscellaneous)chemistry.chemical_elementContrast Mediabrain depositionchemistry.chemical_compoundmedicineAnimalsTissue Distributioniron oxide nanoparticleProspective StudiesMagnetite NanoparticlesPharmacology Toxicology and Pharmaceutics (miscellaneous)Brain Chemistrybusiness.industryBrainMagnetic Resonance ImagingFerrosoferric OxideFerumoxytolDentate nucleuschemistryCase-Control StudiesSwine MiniatureChoroid plexusAdministration IntravenousbusinessIron oxide nanoparticlesEx vivoBiotechnologyResearch PaperMRINanotheranostics
researchProduct